Edwards Lifesciences (EW) Equity Income (2011 - 2013)

Edwards Lifesciences has reported Equity Income for 3 years, with the latest figure at $200000.0 in Q2 2013.

• For the quarter ending Q2 2013, Equity Income changed N/A year-over-year to $200000.0; the trailing twelve-month figure through Jun 2013 stood at $4.3 million (changed N/A YoY), and the FY2012 full-year result was $1.8 million, up 157.14% from the prior year.
• Equity Income for Q2 2013 stood at $200000.0, down from $2.0 million in the prior quarter.
• The five-year high for Equity Income was $2.0 million in Q1 2013, with the low at -$900000.0 in Q1 2011.
• Average Equity Income over 3 years is $625000.0, with a median of $500000.0 recorded in 2011.
• Year-over-year, Equity Income climbed 16.67% in 2012 and jumped 185.71% in 2013.
• Tracing EW's Equity Income over 3 years: stood at $1.2 million in 2011, then advanced by 16.67% to $1.4 million in 2012, then sank by 85.71% to $200000.0 in 2013.
• The last three Equity Income figures came in at $200000.0 (Q2 2013), $2.0 million (Q1 2013), and $1.4 million (Q4 2012), per Business Quant data.

Peer Comparison